Safety Evaluation and antioxidant potential of new probiotic strain

Antioxidant Bacillus subtilis Colon length Feed intake Probiotic safety study Repeated dose toxicity

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
15 Oct 2024
Historique:
received: 21 09 2024
accepted: 26 09 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 15 10 2024
Statut: epublish

Résumé

Probiotics have recently gained significant interest for their possible therapeutic effects in treating numerous health conditions. Probiotics containing

Identifiants

DOI: 10.1016/j.heliyon.2024.e38581 PMID: 39403501 PMC: PMC11471459
pubmed: 39403501
doi: 10.1016/j.heliyon.2024.e38581
pii: S2405-8440(24)14612-9
pmc: PMC11471459
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e38581

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:None declared If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Muhammad Usama Mazhar (MU)

Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

Sadaf Naz (S)

Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

Jehan Zeb Khan (JZ)

Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

Sharjeel Khalid (S)

National Institute for Genomics and Advanced Biotechnology (NIGAB), National Agricultural Research Centre (NARC), Islamabad, Pakistan.

Shakira Ghazanfar (S)

National Institute for Genomics and Advanced Biotechnology (NIGAB), National Agricultural Research Centre (NARC), Islamabad, Pakistan.

Samy Selim (S)

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, 72388, Saudi Arabia.

Muhammad Khalid Tipu (MK)

Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

Sumel Ashique (S)

Department of Pharmaceutics, Bengal College of Pharmaceutical Sciences & Research, Durgapur, 713212, West Bengal, India.

Sabina Yasmin (S)

Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, 62529, Saudi Arabia.

Mohammed S Almuhayawi (MS)

Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Yousef Abdulatif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.

Aziza Alshahrani (A)

Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, 62529, Saudi Arabia.

Mohammad Yousuf Ansari (MY)

MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, 133207, India.

Classifications MeSH